Subject
Gastroenterology,Oncology
Reference11 articles.
1. SUNLIGHT investigators. Trifluridine-tipiracil and bevacizumab in refractory metastatic colorectal cancer;Prager;N Engl J Med,2023
2. The pharmacological costs of first-line therapies in unselected patients with advanced colorectal cancer: a review of published phase III trials;Giuliani;Clin Colorectal Cancer,2016
3. Determina n. 111/2022. (22A01083). (GU Serie Generale n.41 del 18/02/2022). Available at: https://www.gazzettaufficiale.it/eli/id/2022/12/14/22A07037/SG. Accessed: June 30, 2023.
4. Determina n. 2044/2017. (18A00110). (GU Serie Generale n.7 del 10-01-2018). Available at: https://www.gazzettaufficiale.it/atto/serie_generale/caricaDettaglioAtto/originario.atto.dataPubblicazioneGazzetta=2018-01-10&atto.codiceRedazionale=18A00110&elenco30giorni=true. Accessed: June 30, 2023.
5. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS);Cherny;Ann Oncol,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献